ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Addex Therapeutics Ltd.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 15, 2026

$2.89+0.13 (+4.71%)

Close on Oct 19, 2026

Price history

Daily open, high, low, close and volume

Date	Open	High	Low	Close	Change	Volume
Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected.

From SEC filings

Date	Ratio	Effect on per-share figures
Oct 23, 2023	1-for-20 reverse	Earlier per-share figures multiplied by 20

Parsed from the XBRL in Addex Therapeutics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Oct 23, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ADXN.

Advertisement
300 × 250